MoneyWorks4Me

Fermenta Biotech - Quaterly Results

11 Nov 2022 Evaluate
The sales declined to Rs. 901.23 millions for the September 2022 quarter as compared to Rs. 990.10 millions during the corresponding quarter last year.A big decline of -67.58% was reported for the quarter ended September 2022 to Rs. 21.29  millions from Rs. 65.66 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 138.54 millions from 198.95 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 901.23 990.10 -8.98 1745.78 2078.94 -16.03 3879.61 3728.22 4.06
Other Income 25.93 23.52 10.25 64.91 34.24 89.57 75.26 66.18 13.72
PBIDT 138.54 198.95 -30.36 257.80 485.40 -46.89 834.63 1003.36 -16.82
Interest 49.02 44.44 10.31 94.18 86.24 9.21 172.26 180.75 -4.70
PBDT 89.52 154.51 -42.06 163.62 399.16 -59.01 662.37 822.61 -19.48
Depreciation 62.55 59.75 4.69 124.59 114.37 8.94 236.74 190.31 24.40
PBT 26.97 94.76 -71.54 39.03 284.79 -86.30 425.63 632.30 -32.69
TAX 5.68 29.10 -80.48 7.21 91.27 -92.10 123.25 112.60 9.46
Deferred Tax 1.03 12.57 -91.81 0.00 41.54 -100.00 49.18 0.03 163833.33
PAT 21.29 65.66 -67.58 31.82 193.52 -83.56 302.38 519.70 -41.82
Equity 144.24 144.24 0.00 144.24 144.24 0.00 144.24 144.24 0.00
PBIDTM(%) 15.37 20.09 -23.50 14.77 23.35 -36.75 21.51 26.91 -20.06
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..